ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,005 | -58.2% | 13,212 | -48.5% | 0.00% | – |
| Q2 2023 | $172,185 | -52.2% | 25,661 | -38.3% | 0.00% | -100.0% |
| Q1 2023 | $360,455 | -31.3% | 41,623 | -40.9% | 0.00% | 0.0% |
| Q4 2022 | $524,607 | +86.0% | 70,417 | +78.0% | 0.00% | 0.0% |
| Q3 2022 | $282,000 | -59.0% | 39,561 | -55.0% | 0.00% | -50.0% |
| Q2 2022 | $688,000 | -69.6% | 87,870 | -46.2% | 0.00% | -50.0% |
| Q1 2022 | $2,266,000 | +208.7% | 163,290 | +772.2% | 0.00% | +300.0% |
| Q1 2021 | $734,000 | – | 18,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
| Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
| Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
| Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
| BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
| Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
| DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
| Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |